The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder

Bumetanide, a drug being studied in autism spectrum disorder (ASD) may act to restore gamma-aminobutyric acid (GABA) function, which may be modulated by the immune system. However, the interaction between bumetanide and the immune system remains unclear. Seventy-nine children with ASD were analysed...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingyang, Zhang, Lingli, Shan, Haidi, Yu, Juehua, Dai, Yuan, He, Hua, Li, Wei-Guang, Langley, Christelle, Sahakian, Barbara J., Yao, Yin, Luo, Qiang, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166783/
https://www.ncbi.nlm.nih.gov/pubmed/35660740
http://dx.doi.org/10.1038/s41398-022-01987-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166783/
https://www.ncbi.nlm.nih.gov/pubmed/35660740
http://dx.doi.org/10.1038/s41398-022-01987-x

Ejemplares similares